| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0209467683758286 | 0.39274154 |
| NSC 275647 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- | 0.0209467683758286 | 0.45552294 |
| NSC 303861 | L-Cysteine analog | 0.0209467683758286 | 0.33197676 |
| NSC 332488 | 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)- | 0.0209467683758286 | 0.28927695 |
| NSC 339579 | 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate | 0.0209467683758286 | 0.37805951 |
| NSC 351521 | Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) | 0.0209467683758286 | 0.40477388 |
| NSC 603578 | Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) | 0.0209467683758286 | 0.29878223 |
| NSC 633963 | N,N'-Di{1-methyl-2-[1-methyl-2-carboxamido(3-propionamidine) -4-pyrrole]-4-pyrrolyl}suberamide dihydrochloride | 0.0209467683758286 | 0.0036654141 |
| NSC 637505 | Null | 0.0209467683758286 | 0.2462914 |
| NSC 638409 | (E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide | 0.0209467683758286 | 0.34374043 |